Q3KQU3 (MA7D1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 57.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: MAP7 domain-containing protein 1 Alternative name(s): Arginine/proline-rich coiled-coil domain-containing protein 1 Proline/arginine-rich coiled-coil domain-containing protein 1 | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 841 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Subcellular location | |
| Sequence similarities | Belongs to the MAP7 family. |
| Sequence caution | The sequence AAG17244.1 differs from that shown. Reason: Frameshift at positions 80, 207 and 736. The sequence BAA86501.2 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm Cytoskeleton |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Domain | Coiled coil |
| PTM | Isopeptide bond Phosphoprotein Ubl conjugation |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Cellular component | cytoplasm Inferred from electronic annotation. Source: UniProtKB-KW spindleInferred from electronic annotation. Source: UniProtKB-SubCell |
| Complete GO annotation... | |
Alternative products
| This entry describes 4 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q3KQU3-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q3KQU3-2) The sequence of this isoform differs from the canonical sequence as follows: 247-283: Missing. 729-729: Missing. | ||||||
| Isoform 3 (identifier: Q3KQU3-3) The sequence of this isoform differs from the canonical sequence as follows: 1-454: Missing. 455-459: TASEL → MNGPV 570-578: Missing. 729-729: Missing. | ||||||
| Note: No experimental confirmation available. | ||||||
| Isoform 4 (identifier: Q3KQU3-4) The sequence of this isoform differs from the canonical sequence as follows: 325-356: Missing. 729-729: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 841 | 841 | MAP7 domain-containing protein 1 | PRO_0000306807 | |||||
Regions | |||||||||
| Coiled coil | 128 – 222 | 95 | Potential | ||||||
| Coiled coil | 412 – 441 | 30 | Potential | ||||||
| Coiled coil | 593 – 721 | 129 | Potential | ||||||
| Compositional bias | 14 – 127 | 114 | Pro-rich | ||||||
| Compositional bias | 467 – 589 | 123 | Pro-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 41 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 47 | 1 | Phosphothreonine Ref.17 | ||||||
| Modified residue | 51 | 1 | Phosphothreonine Ref.17 | ||||||
| Modified residue | 70 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 72 | 1 | Phosphoserine Ref.18 | ||||||
| Modified residue | 86 | 1 | Phosphoserine Ref.14 Ref.17 Ref.18 | ||||||
| Modified residue | 88 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 97 | 1 | Phosphothreonine Ref.14 | ||||||
| Modified residue | 113 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 116 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 118 | 1 | Phosphothreonine Ref.18 | ||||||
| Modified residue | 123 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 125 | 1 | Phosphoserine Ref.14 Ref.17 Ref.19 | ||||||
| Modified residue | 252 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 274 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 302 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 313 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 399 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 442 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 446 | 1 | Phosphoserine Ref.17 | ||||||
| Modified residue | 460 | 1 | Phosphoserine Ref.11 Ref.12 Ref.14 Ref.16 Ref.17 Ref.18 Ref.19 | ||||||
| Modified residue | 544 | 1 | Phosphoserine Ref.10 Ref.12 Ref.17 Ref.18 Ref.19 | ||||||
| Modified residue | 548 | 1 | Phosphoserine Ref.10 Ref.12 Ref.17 Ref.18 Ref.19 | ||||||
| Modified residue | 552 | 1 | Phosphoserine Ref.12 Ref.17 Ref.18 | ||||||
| Modified residue | 554 | 1 | Phosphothreonine Ref.18 | ||||||
| Modified residue | 576 | 1 | Phosphoserine Ref.15 | ||||||
| Modified residue | 585 | 1 | Phosphothreonine Ref.15 | ||||||
| Modified residue | 741 | 1 | Phosphoserine Ref.10 | ||||||
| Modified residue | 753 | 1 | Phosphoserine Ref.14 | ||||||
| Modified residue | 834 | 1 | Phosphoserine Ref.10 Ref.11 Ref.12 Ref.14 Ref.16 Ref.17 Ref.18 | ||||||
| Cross-link | 439 | Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin) Ref.13 | |||||||
Natural variations | |||||||||
| Alternative sequence | 1 – 454 | 454 | Missing in isoform 3. | VSP_028483 | |||||
| Alternative sequence | 247 – 283 | 37 | Missing in isoform 2. | VSP_028484 | |||||
| Alternative sequence | 325 – 356 | 32 | Missing in isoform 4. | VSP_028485 | |||||
| Alternative sequence | 455 – 459 | 5 | TASEL → MNGPV in isoform 3. | VSP_028486 | |||||
| Alternative sequence | 570 – 578 | 9 | Missing in isoform 3. | VSP_028487 | |||||
| Alternative sequence | 729 | 1 | Missing in isoform 2, isoform 3 and isoform 4. | VSP_028488 | |||||
| Natural variant | 104 | 1 | R → W. Corresponds to variant rs2296266 [ dbSNP | Ensembl ]. | VAR_035312 | |||||
| Natural variant | 531 | 1 | R → S. Corresponds to variant rs12563354 [ dbSNP | Ensembl ]. | VAR_053970 | |||||
Experimental info | |||||||||
| Sequence conflict | 207 | 1 | N → S in AAG17244. Ref.6 | ||||||
| Sequence conflict | 794 | 1 | H → R in BAC04654. Ref.3 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Characterization of cDNA clones selected by the GeneMark analysis from size-fractionated cDNA libraries from human brain." Hirosawa M., Nagase T., Ishikawa K., Kikuno R., Nomura N., Ohara O. DNA Res. 6:329-336(1999) [PubMed: 10574461] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain. |
| [2] | "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones." Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T. DNA Res. 9:99-106(2002) [PubMed: 12168954] [Abstract] Cited for: SEQUENCE REVISION. |
| [3] | "Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. Sugano S.Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). Tissue: Heart and Teratocarcinoma. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 625-841 (ISOFORMS 2/3/4). Tissue: Bone and Uterus. |
| [6] | "Large-scale cDNA transfection screening for genes related to cancer development and progression." Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X., Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X. Gu J.Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004) [PubMed: 15498874] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 77-841 (ISOFORM 4). |
| [7] | "Towards a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs." Wiemann S., Weil B., Wellenreuther R., Gassenhuber J., Glassl S., Ansorge W., Boecher M., Bloecker H., Bauersachs S., Blum H., Lauber J., Duesterhoeft A., Beyer A., Koehrer K., Strack N., Mewes H.-W., Ottenwaelder B., Obermaier B. Poustka A.Genome Res. 11:422-435(2001) [PubMed: 11230166] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 546-841 (ISOFORM 2). Tissue: Amygdala. |
| [8] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 590-841 (ISOFORMS 2/3/4). |
| [9] | "Proteome analysis of the human mitotic spindle." Sauer G., Koerner R., Hanisch A., Ries A., Nigg E.A., Sillje H.H.W. Mol. Cell. Proteomics 4:35-43(2005) [PubMed: 15561729] [Abstract] Cited for: SUBCELLULAR LOCATION, MASS SPECTROMETRY. |
| [10] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399; SER-544; SER-548; SER-741 AND SER-834, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed: 16964243] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-834, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Phosphoproteome analysis of the human mitotic spindle." Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R. Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006) [PubMed: 16565220] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460; SER-544; SER-548; SER-552 AND SER-834, MASS SPECTROMETRY. Tissue: Cervix adenocarcinoma. |
| [13] | "Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry." Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D. Proteomics 7:868-874(2007) [PubMed: 17370265] [Abstract] Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-439, MASS SPECTROMETRY. Tissue: Mammary cancer. |
| [14] | "Evaluation of the low-specificity protease elastase for large-scale phosphoproteome analysis." Wang B., Malik R., Nigg E.A., Korner R. Anal. Chem. 80:9526-9533(2008) [PubMed: 19007248] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-86; SER-88; THR-97; SER-123; SER-125; SER-252; SER-460; SER-753 AND SER-834, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [15] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed: 18220336] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-302; SER-313; SER-576 AND THR-585, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [16] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-834, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [17] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; THR-47; THR-51; SER-86; SER-113; SER-116; SER-125; SER-442; SER-446; SER-460; SER-544; SER-548; SER-552 AND SER-834, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [18] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; SER-86; THR-118; SER-460; SER-544; SER-548; SER-552; THR-554 AND SER-834, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [19] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-125; SER-460; SER-544 AND SER-548, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AB033013 mRNA. Translation: BAA86501.2. Different initiation. AK001212 mRNA. Translation: BAA91557.1. AK095939 mRNA. Translation: BAC04654.1. CH471059 Genomic DNA. Translation: EAX07381.1. CH471059 Genomic DNA. Translation: EAX07382.1. BC027334 mRNA. Translation: AAH27334.1. BC106053 mRNA. Translation: AAI06054.1. AF218002 mRNA. Translation: AAG17244.1. Frameshift. AL136547 mRNA. Translation: CAB66482.2. CR457254 mRNA. Translation: CAG33535.1. |
| IPI | IPI00167009. IPI00645814. IPI00654605. IPI00867630. |
| RefSeq | NP_060537.3. NM_018067.3. |
| UniGene | Hs.356096. |
3D structure databases | |
| ProteinModelPortal | Q3KQU3. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | Q3KQU3. 9 interactions. |
| MINT | MINT-2874531. |
| STRING | Q3KQU3. |
PTM databases | |
| PhosphoSite | Q3KQU3. |
Polymorphism databases | |
| DMDM | 121942584. |
Proteomic databases | |
| PRIDE | Q3KQU3. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000373151; ENSP00000362244; ENSG00000116871. |
| GeneID | 55700. |
| KEGG | hsa:55700. |
| UCSC | uc001bzz.1. human. uc001caa.1. human. uc001cab.1. human. uc001cad.1. human. |
Organism-specific databases | |
| CTD | 55700. |
| GeneCards | GC01P036621. |
| H-InvDB | HIX0000427. |
| HGNC | HGNC:25514. MAP7D1. |
| HPA | HPA028075. |
| neXtProt | NX_Q3KQU3. |
| PharmGKB | PA162394970. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| HOVERGEN | HBG071099. |
| InParanoid | Q3KQU3. |
| OMA | AMKNATS. |
Gene expression databases | |
| ArrayExpress | Q3KQU3. |
| Bgee | Q3KQU3. |
| CleanEx | HS_MAP7D1. |
| Genevestigator | Q3KQU3. |
Family and domain databases | |
| InterPro | IPR008604. E-MAP-115. [Graphical view] |
| PANTHER | PTHR15073. E-MAP-115. 1 hit. |
| Pfam | PF05672. MAP7. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| NextBio | 60538. |
Entry information
| Entry name | MA7D1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q3KQU3 Secondary accession number(s): D3DPS4 Q9ULN3 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 1 Human chromosome 1: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| SIMILARITY comments Index of protein domains and families |

Clusters with